Insulin therapy, duration of diabetes linked to cancer risk

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1324, 2010-01, pp. : 7-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin therapy and cancer risk in diabetes mellitus

By Platts Julia  

Clinical Medicine, Vol. 10, Iss. 5, 2010-10 ,pp. : 509-512

Royal College Of Physicians

Access to resources Recommend Favorite

Insulin therapy increases colorectal cancer risk

By  

Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Insulin glargine: commentary on the duration of action and lower risk of nocturnal hypoglycaemia in patients with diabetes

By Rosenstock Julio   Owens David  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 1, 2004-01 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Insulin analogues and other developments in insulin therapy for diabetes

By McAulay Vincent   Frier Brian M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1141-1156

Informa Healthcare

Access to resources Recommend Favorite

Higher doses of insulin glargine linked to cancer

By  

Reactions Weekly, Vol. 1, Iss. 1308, 2010-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite